Long-term results of liver transplantation for hepatocellular carcinoma
https://doi.org/10.23873/2074-0506-2012-0-3-15-21
Abstract
In this article we presented the new approach to the liver transplantation based on the prognosis paradigm of the tumor recurrence before the operation using largest experience of the liver transplantation in Russia. The effect independent clinicopathologic factors on outcome were tested using univariate and multivariate analyses by the Cox regression. The value molecular biomarker for choice of the patients to the transplantation liver was presented.
About the Authors
M. Sh. Khubutia
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
Y. A. Kovalenko
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
A. O. Chugunov
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
A. V. Chzhao
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
K. R. Dzhagraev
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
A. A. Salienko
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
O. I. Andreytseva
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
L. V. Donova
Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
References
1. Accuracy of staging as a predictor for reccurence after liver transplantation for hepatocellular carcinoma / S. A. Shah [et al.] // Transplantation. – 2006. – Vol. 81. – p. 1633–1639.
2. Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status / A. Marshall [et al.] // Liver Transpl. – 2010. – Vol. 16 (3). – p. 279–288.
3. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era / D.M. Levi [et al.] // J.Am. Coll. Surg. – 2010. – Vol. 210. – p. 727–736.
4. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22–year experience with 467 patients at UCLA / J.P. Duffy [et al.] // Ann. Surg. – 2007. – Vol. 246. – p. 502–509.
5. Todo, S. Living donor liver transplantation for adult patients with hepatocellular carcinoma / S. Todo, H. Furukawa // Ann. Surg. – 2004. – Vol. 240. – p. 451–461.
6. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impct on long-term survival / R.T. Poon [et al.] // Ann. Surg. – 2007. – Vol. 245. – p. 51–58.
7. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma / K.K. Lee [et al.] // J. Surg. Oncol. – 2010. – Vol. 101. – p. 47–53.
8. Llovet, J. M. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation / J. M. Llovet, J. Fuster, J. Bruix // Hepatology. – 1999. – Vol. 30. – p. 1434–1440.
9. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis / V. Mazzaferro [et al.] // N. Engl. J. Med. – 1996. – Vol. 334. – p. 693–699.
10. Liver Transplantation for Hepatocellular Carcinoma: Defining the Impact of Using Extended Criteria Liver Allografts / M. E. Facciuto [et al.] // Transplantation. – 2011. – Vol. 92. – p. 446–452.
11. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival / F.Y. Yao [et al.] // Hepatology. – 2001. – Vol. 33. – p. 1394–1403.
12. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients / B. Ringe [et al.] // World J. Surg. – 1991. – Vol. 15. – p. 270–285.
13. Hepatic resection versus transplantation for hepatocellular carcinoma / S. Iwatsuki [et al.] // Ann. Surg. – 1991. – Vol. 214. – p. 221–229.
14. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? / H. Bismuth [et al.] // Transplant. Proc. – 1993. – Vol. 25. – p. 1066–1067.
15. Lencioni, R. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma / R. Lencioni, J.M. Llovet // Sem. Liver Dis. – 2010. – Vol. 30 (1). – p. 52–60.
16. Proceedings of the 2010 International Consensus Conference on liver transplantation for HCC. 2–4 December 2010. – Zurich. http: // www.OLT4HCC.org.
17. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study / A. Grasso [et al.] // Transplantation. – 2006. – Vol. 81 (11). – p. 1532–1541.
18. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence / M. Vivarelli [et al.] // Ann Surg. – 2008. – Vol. 248 (5). – p. 857–862.
19. D'Amico, F. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria / F. D’Amico, M. Schwartz, A. Vitale // Liver transplantation. – 2009. – Vol. 15. – p. 1278–1287.
20. A prospective, randomized, multicentre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma / G. Söderdahl [et al.] // Transpl. Int. – 2006. – Vol. 19 (4). – p. 288–294.
21. Benefit of downsizing hepatocellular carcinoma in a livertransplant population / J.W. Jang [et al.] // Aliment. Pharmacol. Ther. – 2009. – Vol. 31. – p. 415–423.
22. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China / J. Fan [et al.]// J. Cancer Res. Clin. Oncol. – 2009. – Vol. 135 (10). – p. 1403–1412.
23. Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients / J. Li [et al.] // World J. Gastroenterol. – 2009. – Vol. 15 (33). – p. 4170–4176.
24. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma / C. Zavaglia [et al.] // Am. J. Gastroenterol. – 2005. – Vol. 100 (12). – p. 2708–2716.
25. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis / O. Barakat [et al.] // Liver Transpl. – 2010. – Vol. 16 (3). – p. 289–299.
26. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score / L. Marelli [et al.] // Ann. Surg. Oncol. – 2008. – Vol. 15 (12). – p. 3503– 3511.
27. Mazzaferro, V. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis / V. Mazzaferro, J. M. Llovet, R. Micelincet // Oncol. – 2009. – Vol. 10 (1). – p. 35–43.
28. Llovet, J.M. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma / J.M. Llovet, J. Fuster, J. Bruix // Liver. Transpl. – 2004. – Vol. 10. – p. 115–120.
29. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time / T. Decaens [et al.] // Liver Transpl. – 2006. – Vol. 12 (12). – p. 1761–1769.
30. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database / C. Toso [et al.] // Hepatology. – 2009. – Vol. 49 (3). – p. 832–838.
Review
For citations:
Khubutia M.Sh., Kovalenko Y.A., Chugunov A.O., Chzhao A.V., Dzhagraev K.R., Salienko A.A., Andreytseva O.I., Donova L.V. Long-term results of liver transplantation for hepatocellular carcinoma. Transplantologiya. The Russian Journal of Transplantation. 2012;(3):15-21. (In Russ.) https://doi.org/10.23873/2074-0506-2012-0-3-15-21
Views:
681
Email this article 